The use of TIPS in chronic liver disease

The development of cirrhosis and portal hypertension in the natural history of chronic liver disease is associated with many complications. A transjugular intrahepatic portosystemic stent shunt (TIPS) is a metal prosthesis that has been shown to be very effective in lowering sinusoidal portal pressu...

Full description

Bibliographic Details
Main Author: Florence Wong
Format: Article
Language:English
Published: Elsevier 2006-01-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119320332
id doaj-780f2f0a274640af82fae358aefa0158
record_format Article
spelling doaj-780f2f0a274640af82fae358aefa01582021-06-08T04:36:20ZengElsevierAnnals of Hepatology1665-26812006-01-0151515The use of TIPS in chronic liver diseaseFlorence Wong0Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada; Address for correspondence:The development of cirrhosis and portal hypertension in the natural history of chronic liver disease is associated with many complications. A transjugular intrahepatic portosystemic stent shunt (TIPS) is a metal prosthesis that has been shown to be very effective in lowering sinusoidal portal pressure, and therefore is effective in the management of complications of cirrhosis, especially those related to portal hypertensive bleeding and sodium and water retention. In patients with acute variceal bleeding not responding to pharmacologic and endoscopic treatments, a reduction of the hepatic venous pressure gradient to < 12 mmHg or by > 20% with TIPS has been shown to be effective in controlling the acute bleed and in preventing rebleeding. For stable patients whose acute variceal bleed is controlled, TIPS is equal to combined beta-blocker and band ligation in the prevention of recurrent variceal bleed. TIPS is also more effective than large volume paracentesis in the control of refractory ascites, and may confer a survival advantage over repeated large volume paracentesis. TIPS has also been used in the management of other complications related to portal hypertension including ectopic varices, hepatic hydrothorax, and hepatorenal syndrome with some success, but experience is still rather limited. Miscellaneous uses include treatment of Budd Chiari Syndrome, portal hypertensive gastropathy and hepatopulmonary syndrome. Careful patient selection is vital to a successful outcome, as patients with severe liver dysfunction tend to die post-TIPS despite a functioning shunt. All patients who require a TIPS for treatment of complications of cirrhosis should be referred for consideration of liver transplant.http://www.sciencedirect.com/science/article/pii/S1665268119320332Cirrhosistransjugular intrahepatic por-tosystemic stent shuntvariceal bleedascitesportal hypertension
collection DOAJ
language English
format Article
sources DOAJ
author Florence Wong
spellingShingle Florence Wong
The use of TIPS in chronic liver disease
Annals of Hepatology
Cirrhosis
transjugular intrahepatic por-tosystemic stent shunt
variceal bleed
ascites
portal hypertension
author_facet Florence Wong
author_sort Florence Wong
title The use of TIPS in chronic liver disease
title_short The use of TIPS in chronic liver disease
title_full The use of TIPS in chronic liver disease
title_fullStr The use of TIPS in chronic liver disease
title_full_unstemmed The use of TIPS in chronic liver disease
title_sort use of tips in chronic liver disease
publisher Elsevier
series Annals of Hepatology
issn 1665-2681
publishDate 2006-01-01
description The development of cirrhosis and portal hypertension in the natural history of chronic liver disease is associated with many complications. A transjugular intrahepatic portosystemic stent shunt (TIPS) is a metal prosthesis that has been shown to be very effective in lowering sinusoidal portal pressure, and therefore is effective in the management of complications of cirrhosis, especially those related to portal hypertensive bleeding and sodium and water retention. In patients with acute variceal bleeding not responding to pharmacologic and endoscopic treatments, a reduction of the hepatic venous pressure gradient to < 12 mmHg or by > 20% with TIPS has been shown to be effective in controlling the acute bleed and in preventing rebleeding. For stable patients whose acute variceal bleed is controlled, TIPS is equal to combined beta-blocker and band ligation in the prevention of recurrent variceal bleed. TIPS is also more effective than large volume paracentesis in the control of refractory ascites, and may confer a survival advantage over repeated large volume paracentesis. TIPS has also been used in the management of other complications related to portal hypertension including ectopic varices, hepatic hydrothorax, and hepatorenal syndrome with some success, but experience is still rather limited. Miscellaneous uses include treatment of Budd Chiari Syndrome, portal hypertensive gastropathy and hepatopulmonary syndrome. Careful patient selection is vital to a successful outcome, as patients with severe liver dysfunction tend to die post-TIPS despite a functioning shunt. All patients who require a TIPS for treatment of complications of cirrhosis should be referred for consideration of liver transplant.
topic Cirrhosis
transjugular intrahepatic por-tosystemic stent shunt
variceal bleed
ascites
portal hypertension
url http://www.sciencedirect.com/science/article/pii/S1665268119320332
work_keys_str_mv AT florencewong theuseoftipsinchronicliverdisease
AT florencewong useoftipsinchronicliverdisease
_version_ 1721390923587256320